Used in biomedical research to quantify RUNX2 protein levels in cell lysates or tissue extracts, this ELISA kit supports studies on osteoblast differentiation and bone formation. It is widely applied in bone metabolism research, helping to investigate conditions like osteoporosis, fracture healing, and skeletal development. Researchers also use it in cancer studies, particularly in cancers affecting bone, such as osteosarcoma, to understand the role of RUNX2 in tumor progression and bone remodeling. The assay provides a reliable and sensitive method for measuring RUNX2 in experimental models, aiding drug development and mechanistic studies in cell signaling pathways related to bone health and disease.